{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:44Z","timestamp":1772119544654,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F31 CA247105"],"award-info":[{"award-number":["F31 CA247105"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10552-023-01675-1","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T10:03:13Z","timestamp":1677578593000},"page":"449-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient and provider-level drivers of healthcare utilization related to a diagnosis of a precancerous condition: monoclonal gammopathy of undetermined significance (MGUS)"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2376-7656","authenticated-orcid":false,"given":"Maira A.","family":"Casta\u00f1eda-Avila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Mazor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate L.","family":"Lapane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara M.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"1675_CR1","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1182\/asheducation-2013.1.478","volume":"2013","author":"O Landgren","year":"2013","unstructured":"Landgren O (2013) Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies. Hematol Am Soc Hematol Educ Progr 2013:478\u2013487","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"1675_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clml.2014.09.004","volume":"15","author":"RS Go","year":"2015","unstructured":"Go RS, Gundrum JD, Neuner JM (2015) Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis. Clin Lymphoma Myeloma Leuk 15:177-186.e4","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1675_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/jamaoncol.2015.23","volume":"1","author":"EE Sigurdardottir","year":"2015","unstructured":"Sigurdardottir EE et al (2015) The role of diagnosis and clinical follow-up of monoclonal gammopathy of undetermined significance on survival in multiple myeloma. JAMA Oncol 1:168\u2013174","journal-title":"JAMA Oncol"},{"key":"1675_CR4","doi-asserted-by":"publisher","first-page":"933","DOI":"10.4065\/mcp.2010.0337","volume":"85","author":"RK Wadhera","year":"2010","unstructured":"Wadhera RK, Rajkumar SV (2010) Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc 85:933\u2013942","journal-title":"Mayo Clin Proc"},{"key":"1675_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA et al (2010) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24:1121\u20131127","journal-title":"Leukemia"},{"key":"1675_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","volume":"179","author":"U Axelsson","year":"1966","unstructured":"Axelsson U, Bachmann R, H\u00e4ll\u00e9n J (1966) Frequency of pathological proteins (M-components) om 6995 sera from an adult population. Acta Med Scand 179:235\u2013247","journal-title":"Acta Med Scand"},{"issue":"5","key":"1675_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1182\/blood.V40.5.719.719","volume":"40","author":"RA Kyle","year":"1972","unstructured":"Kyle RA, Finkelstein S, Elveback LR, Kurland LT (1972) Incidence of monoclonal proteins in a minnesota community with a cluster of multiple myeloma. Blood 40(5):719\u2013724","journal-title":"Blood"},{"key":"1675_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/jcp.35.1.63","volume":"35","author":"JP Saleun","year":"1982","unstructured":"Saleun JP, Vicariot M, Deroff P, Morin JF (1982) Monoclonal gammopathies in the adult population of Finist\u00e8re. France J Clin Pathol 35:63\u201368","journal-title":"France J Clin Pathol"},{"key":"1675_CR9","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/leu.2009.134","volume":"23","author":"O Landgren","year":"2009","unstructured":"Landgren O, Weiss BM (2009) Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis. Leukemia 23:1691\u20131697","journal-title":"Leukemia"},{"key":"1675_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.seminhematol.2010.11.003","volume":"48","author":"A Zingone","year":"2011","unstructured":"Zingone A, Kuehl WM (2011) Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma. Semin Hematol 48:4\u201312","journal-title":"Semin Hematol"},{"key":"1675_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa1709974","volume":"378","author":"RA Kyle","year":"2018","unstructured":"Kyle RA et al (2018) Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med 378:241\u2013249","journal-title":"N Engl J Med"},{"key":"1675_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA et al (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346:564\u2013569","journal-title":"N Engl J Med"},{"key":"1675_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41408-019-0172-1","volume":"9","author":"I Maatouk","year":"2019","unstructured":"Maatouk I et al (2019) Patients with precursor disease exhibit similar psychological distress and mental HRQOL as patients with active myeloma. Blood Cancer J 9:9","journal-title":"Blood Cancer J"},{"key":"1675_CR14","doi-asserted-by":"publisher","first-page":"101901","DOI":"10.1016\/j.ejon.2021.101901","volume":"51","author":"B Murphy","year":"2021","unstructured":"Murphy B et al (2021) Patient\u2019s perspectives of living with a precancerous condition: monoclonal gammopathy of undetermined significance (MGUS). Eur J Oncol Nurs 51:101901","journal-title":"Eur J Oncol Nurs"},{"issue":"11","key":"1675_CR15","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1182\/blood-2009-06-229120","volume":"114","author":"RS Go","year":"2009","unstructured":"Go RS, Doyle LM (2009) A monoclonal gammopathy in search of clinical significance: 57 years later. Blood 114(11):2355\u20132356","journal-title":"Blood"},{"key":"1675_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/ACM.0b013e31823ab7d2","volume":"87","author":"PA Harris","year":"2012","unstructured":"Harris PA et al (2012) ResearchMatch: a national registry to recruit volunteers for clinical research. Acad Med 87:66\u201373","journal-title":"Acad Med"},{"key":"1675_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.invent.2016.02.001","volume":"4","author":"L Thornton","year":"2016","unstructured":"Thornton L et al (2016) Recruiting for health, medical or psychosocial research using Facebook: systematic review. Internet Interv 4:72\u201381","journal-title":"Internet Interv"},{"key":"1675_CR18","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1249\/01.mss.0000172593.20181.14","volume":"37","author":"PR Ulin","year":"2005","unstructured":"Ulin PR, Robinson ET, Tolley EE (2005) Qualitative methods in public health: a field guide for applied research. Med Sci Sport Exerc 37:1249","journal-title":"Med Sci Sport Exerc"},{"key":"1675_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"H-F Hsieh","year":"2005","unstructured":"Hsieh H-F, Shannon SE (2005) Three approaches to qualitative content analysis. Qual Health Res 15:1277\u20131288","journal-title":"Qual Health Res"},{"key":"1675_CR20","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1002\/cncr.28148","volume":"119","author":"KJ Fisher","year":"2013","unstructured":"Fisher KJ et al (2013) The effects of primary care on breast cancer mortality and incidence among Medicare beneficiaries. Cancer 119:2964\u20132972","journal-title":"Cancer"},{"key":"1675_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1370\/afm.1398","volume":"10","author":"RG Roetzheim","year":"2012","unstructured":"Roetzheim RG et al (2012) Influence of primary care on breast cancer outcomes among Medicare beneficiaries. Ann Fam Med 10:401\u2013411","journal-title":"Ann Fam Med"},{"key":"1675_CR22","unstructured":"Wilson RT (2000) The role of primary care patterns in stage at diagnosis outcomes among American Indian cancer patients: New Mexico and Arizona, 1994\u20131997. ProQuest Dissertations and Theses. The University of Iowa"},{"key":"1675_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.7326\/0003-4819-159-7-201310010-00003","volume":"159","author":"JM Ferrante","year":"2013","unstructured":"Ferrante JM et al (2013) Primary care utilization and colorectal cancer incidence and mortality among Medicare beneficiaries: a population-based, case-control study. Ann Intern Med 159:437\u2013446","journal-title":"Ann Intern Med"},{"key":"1675_CR24","doi-asserted-by":"publisher","first-page":"432892","DOI":"10.6064\/2012\/432892","volume":"2012","author":"L Shi","year":"2012","unstructured":"Shi L (2012) The impact of primary care: a focused review. Scientifica 2012:432892","journal-title":"Scientifica"},{"key":"1675_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.mayocpiqo.2017.06.002","volume":"1","author":"RS Go","year":"2017","unstructured":"Go RS, Heien HC, Sangaralingham LR, Habermann EB, Shah ND (2017) Monoclonal gammopathy of undetermined significance. Mayo Clin Proc Innov Qual Outcomes 1:161\u2013169","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"1675_CR26","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3324\/haematol.2009.010066","volume":"94","author":"SY Kristinsson","year":"2009","unstructured":"Kristinsson SY et al (2009) Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study. Haematologica 94:1714\u20131720","journal-title":"Haematologica"},{"key":"1675_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1200\/JCO.2017.35.8_suppl.12","volume":"35","author":"E Maiese","year":"2017","unstructured":"Maiese E, Evans K, Chu B-C, Irwin DE (2017) Trends in survival and costs among U.S. patients with multiple myeloma. J Clin Oncol 35:12\u201312","journal-title":"J Clin Oncol"},{"key":"1675_CR28","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.mayocp.2019.12.033","volume":"95","author":"A Ravindran","year":"2020","unstructured":"Ravindran A et al (2020) Monoclonal gammopathy of undetermined significance: indications for prediagnostic testing, subsequent diagnoses, and follow-up practice at Mayo Clinic. Mayo Clin Proc 95:944\u2013954","journal-title":"Mayo Clin Proc"},{"key":"1675_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ejh.12962","volume":"100","author":"CM McShane","year":"2018","unstructured":"McShane CM, Murphy B, Lim KH, Anderson LA (2018) Monoclonal gammopathy of undetermined significance as viewed by haematology healthcare professionals. Eur J Haematol 100:20\u201326","journal-title":"Eur J Haematol"},{"key":"1675_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1200\/JOP.2014.001543","volume":"11","author":"F Khimani","year":"2015","unstructured":"Khimani F, Curley B, Almubarak M (2015) Survey of patients referred to a University Cancer Center for Benign Hematology: quality measures and patient understanding. J Oncol Pract 11:26\u201329","journal-title":"J Oncol Pract"},{"key":"1675_CR31","first-page":"147","volume":"49","author":"KD Bertakis","year":"2000","unstructured":"Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA (2000) Gender differences in the utilization of health care services. J Fam Pract 49:147\u2013152","journal-title":"J Fam Pract"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01675-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-023-01675-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01675-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T13:05:27Z","timestamp":1681563927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-023-01675-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1675"],"URL":"https:\/\/doi.org\/10.1007\/s10552-023-01675-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1820862\/v1","asserted-by":"object"}]},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"3 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial relationship or any conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}